Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA010851-01
Application #
2013905
Study Section
Special Emphasis Panel (SRCD (20))
Project Start
1996-09-30
Project End
2001-08-31
Budget Start
1996-09-30
Budget End
1997-08-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Yale University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Avants, S Kelly; Margolin, Arthur; Usubiaga, Mary Helen et al. (2004) Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy. J Subst Abuse Treat 26:67-78
Copenhaver, Michael; Avants, S Kelly; Warburton, Lara A et al. (2003) Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment. J Psychoactive Drugs 35:209-18
Margolin, Arthur; Avants, S Kelly; Warburton, Lara A et al. (2003) A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol 22:223-8
Margolin, Arthur; Avants, S Kelly; Warburton, Lara A et al. (2002) Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drug users. AIDS Patient Care STDS 16:255-67
Avants, S K; Warburton, L A; Margolin, A (2001) Spiritual and religious support in recovery from addiction among HIV-positive injection drug users. J Psychoactive Drugs 33:39-45
Avants, S K; Margolin, A; Warburton, L A et al. (2001) Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. Am J Addict 10:69-78
Avants, S K; Warburton, L A; Margolin, A (2001) How injection drug users coped with testing HIV-seropositive: implications for subsequent health-related behaviors. AIDS Educ Prev 13:207-18
Avants, S K; Warburton, L A; Hawkins, K A et al. (2000) Continuation of high-risk behavior by HIV-positive drug users. Treatment implications. J Subst Abuse Treat 19:15-22